Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapyMargaret May, Caroline Sabin, Mark Gompels et al.|AIDS|2014Cited by 597
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort studyJemma L. O’Connor, Russell J. Everett, Colette Smith et al.|The Lancet HIV|2017Cited by 67
Antiretroviral Therapy for HIV-2 Infected PatientsN A Smith, Judith Breuer, T R Shaw et al.|Journal of Infection|2001Cited by 56
A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort studySophie José, John Walsh, Valérie Delpech et al.|The Lancet HIV|2018Cited by 51
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral TherapySudeep Pushpakom, John Whitehead, Mayur Chauhan et al.|Clinical Infectious Diseases|2019Cited by 27